Comprehensive analysis of transcriptome sequencing data in the lung tissues of COPD subjects

International Journal of Genomics

Volumn 2015, Issue , 2015, Pages

  Kim, Woo Jin ^a   Lim, Jae Hyun ^b   Lee, Jae Seung ^c   Lee, Sang Do ^c   Kim, Ju Han ^b   Oh, Yeon Mok ^c  

^a Kangwon National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CELLULAR PARAMETERS; CHROMATIN MODIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; GENETIC ANALYZER; HISEQ 2000 SYSTEM.; HUMAN; HUMAN TISSUE; LUNG DIFFUSION CAPACITY; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA ISOLATION; RNA SEQUENCE; SPIROMETRY; TRANSCRIPTOMICS;

EID: 84925310744     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2015/206937     Document Type: Article

References (36)

1. J. Vestbo, S. S. Hurd, A. G. Agustí et al., "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary," American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 4, pp. 347-365, 2013.
2. M. G. Cosio, M. Saetta, and A. Agusti, "Immunologic aspects of chronic obstructive pulmonary disease," The New England Journal of Medicine, vol. 360, no. 23, pp. 2445-2454, 2009.
3. W. Ning, C. J. Li, N. Kaminski et al., "Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 41, pp. 14895-14900, 2004.
4. H. A. Golpon, C. D. Coldren, M. R. Zamora et al., "Emphysema lung tissue gene expression profiling," The American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 6, pp. 595-600, 2004.
5. A. Spira, J. Beane, V. Pinto-Plata et al., "Gene expression profiling of human lung tissue from smokers with severe emphysema," American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 6, pp. 601-610, 2004.
6. I.-M. Wang, S. Stepaniants, Y. Boie et al., "Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer," The American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 4, pp. 402-411, 2008.
7. S. Bhattacharya, S. Srisuma, D. L. Demeo et al., "Molecular biomarkers for quantitative and discrete COPD phenotypes," American Journal of Respiratory Cell and Molecular Biology, vol. 40, no. 3, pp. 359-367, 2009.
8. S. M. S. Francis, J. E. Larsen, S. J. Pavey et al., "Expression profiling identifies genes involved in emphysema severity," Respiratory Research, vol. 10, article 81, 2009.
9. K. Steiling, M. van den Berge, K. Hijazi et al., "A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment," American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 9, pp. 933-942, 2013.
10. A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, and B. Wold, "Mapping and quantifying mammalian transcriptomes by RNA-Seq," Nature Methods, vol. 5, no. 7, pp. 621-628, 2008.
11. F. Ozsolak and P. M. Milos, "RNA sequencing: advances, challenges and opportunities," Nature Reviews Genetics, vol. 12, no. 2, pp. 87-98, 2011.
12. V. Costa, M. Aprile, R. Esposito, and A. Ciccodicola, "RNASeq and human complex diseases: recent accomplishments and future perspectives," European Journal of Human Genetics, vol. 21, no. 2, pp. 134-142, 2013.
13. J. Beane, J. Vick, F. Schembri et al., "Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq," Cancer Prevention Research, vol. 4, no. 6, pp. 803-817, 2011.
14. N.R. Hackett, M.W. Butler, R. Shaykhiev et al., "RNA-Seqquantification of the human small airway epithelium transcriptome," BMC Genomics, vol. 13, no. 1, article 82, 2012.
15. M. R. Miller, J. Hankinson, V. Brusasco et al., "Standardisation of spirometry," European Respiratory Journal, vol. 26, no. 2, pp. 319-338, 2005.
16. C. Trapnell, A. Roberts, L. Goff et al., "Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks," Nature Protocols, vol. 7, no. 3, pp. 562-578, 2012.
17. C. Trapnell, L. Pachter, and S. L. Salzberg, "TopHat: discovering splice junctions with RNA-Seq," Bioinformatics, vol. 25, no. 9, pp. 1105-1111, 2009.
18. C. Trapnell, B. A. Williams, G. Pertea et al., "Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation," Nature Biotechnology, vol. 28, no. 5, pp. 511-515, 2010.
19. J. H. Kim, "Chapter 8: biological knowledge assembly and interpretation," PLoS Computational Biology, vol. 8, no. 12, Article ID e1002858, 2012.
20. S. Shen, J.W. Park, J. Huang et al., "MATS: a Bayesianframework for flexible detection of differential alternative splicing from RNA-Seq data," Nucleic Acids Research, vol. 40, no. 8, p. e61, 2012.
21. S. Anders, A. Reyes, and W. Huber, "Detecting differential usage of exons from RNA-seq data," Genome Research, vol. 22, no. 10, pp. 2008-2017, 2012.
22. J. Lamb, E. D. Crawford, D. Peck et al., "The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease," Science, vol. 313, no. 5795, pp. 1929-1935, 2006.
23. J. E. Zeskind, M. E. Lenburg, and A. Spira, "Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management," Proceedings of the American Thoracic Society, vol. 5, no. 8, pp. 834-841, 2008.
24. N. Soulitzis, E. Neofytou, M. Psarrou et al., "Downregulation of lung mitochondrial prohibitin in COPD," Respiratory Medicine, vol. 106, no. 7, pp. 954-961, 2012.
25. A. DiPietro, G. Visalli, B. Baluce et al., "Multigenerational mitochondrial alterations in pneumocytes exposed to oil fly ash metals," International Journal of Hygiene and Environmental Health, vol. 214, no. 2, pp. 138-144, 2011.
26. 2 levels cause mitochondrial dysfunction and impair cell proliferation," The Journal of Biological Chemistry, vol. 286, no. 43, pp. 37067-37076, 2011.
27. S. Meiners and O. Eickelberg, "What shall we do with the damaged proteins in lung disease? Ask the proteasome!," European Respiratory Journal, vol. 40, no. 5, pp. 1260-1268, 2012.
28. D. Malhotra, R. Thimmulappa, N. Vij et al., "Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity," The American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 12, pp. 1197-1207, 2009.
29. S.-Y. Kim, J.-H. Lee, J. W. Huh et al., "Bortezomib alleviates experimental pulmonary arterial hypertension," American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 5, pp. 698-708, 2012.
30. H. van Hees, C. Ottenheijm, L. Ennen, M. Linkels, R. Dekhuijzen, and L. Heunks, "Proteasome inhibition improves diaphragm function in an animal model for COPD," American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 301, no. 1, pp. 110-116, 2011.
31. I. V. Yang and D. A. Schwartz, "Epigenetic control of gene expression in the lung," American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 10, pp. 1295-1301, 2011.
32. P. Wang, C. Lin, E. R. Smith et al., "Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II," Molecular and Cellular Biology, vol. 29, no. 22, pp. 6074-6085, 2009.
33. M. Murawska and A. Brehm, "CHD chromatin remodelers and the transcription cycle," Transcription, vol. 2, no. 6, pp. 244-253, 2011.
34. K. Ito, M. Ito, W. M. Elliott et al., "Decreased histone deacetylase activity in chronic obstructive pulmonary disease," The New England Journal of Medicine, vol. 352, no. 19, pp. 1967-1976, 2005.
35. J. D. Campbell, J. E. McDonough, J. E. Zeskind et al., "A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK," Genome Medicine, vol. 4, no. 8, p. 67, 2012.
36. A. Kalsotra and T. A. Cooper, "Functional consequences of developmentally regulated alternative splicing," Nature Reviews Genetics, vol. 12, no. 10, pp. 715-729, 2011.